Development of a simvastatin loaded injectable porous scaffold in situ formed by phase inversion method for bone tissue regeneration

Abstract

Introduction:

The use of injectable scaffolds as a minimally invasive method is a good choice in tissue engineering applications. A critical parameter for the tissue engineering scaffolds is a suitable morphology with interconnected pores. We present the development of a simvastatin loaded scaffold that forms in situ and provides the porous structure with interconnected pores.

Methods:

The formulation of these scaffolds includes a polymeric solution of poly lactic-co-glycolic acid (25 wt%) in N-methyl-2-pyrrolidone containing 6 wt% deionized water and porogen (mannitol, four times the weight of the polymer). We have grafted simvastatin to poly lactic-co-glycolic acid by the esterification reactions. Simvastatin or simvastatin-grafted poly lactic-co-glycolic acid in different levels was added to polymer solution and finally the solution was injected into phosphate buffered saline. The simvastatin-grafted poly lactic-co-glycolic acid was characterized by attenuated total reflection Fourier-transform infra-red and ¹H-nuclear magnetic resonance spectroscopy. The morphology, porosity, and biocompatibility of the scaffolds were evaluated. The in vitro simvastatin release from the various formulations was studied. Osteogenic differentiation of the adipose-derived stem cells was investigated using alkaline phosphatase activity assay and cell mineralization was evaluated using Alizarin red staining.

Results:

The morphology results showed the resultant scaffold was porous with the interconnected pores. The scaffolds presented 91% porosity. Non-toxic doses of simvastatin in the scaffolds were determined by methyl-thiazolyl diphenyl-tetrazolium bromide assay. The released simvastatin from the scaffolds continues over 80 days. Alkaline phosphatase activity and Alizarin red results indicated that cell osteogenic differentiation is promoted.

Conclusion:

The results demonstrated that release of simvastatin from the injectable scaffolds can have positive effects on osteogenic differentiation of the adipose-derived stem cells.

Keywords

In situ forming osteogenic differentiation porous scaffold simvastatin

Get full access to this article

View all access options for this article.

References

Baumann

Kang

Stanwick

et al . An injectable drug delivery platform for sustained combination therapy. J Control Release 2009; 138(3): 205–213.

Vikingsson

Sancho-Tello

Ruiz-Saurí

et al . Implantation of a polycaprolactone scaffold with subchondral bone anchoring ameliorates nodules formation and other tissue alterations. Int J Artif Organs 2015; 38(12): 659–666.

Loh

Choong

Three-dimensional scaffolds for tissue engineering applications: role of porosity and pore size. Tissue Eng Part B Rev 2013; 19(6): 485–502.

Alarake

Frohberg

Groth

et al . Mechanical properties and biocompatibility of in situ enzymatically cross-linked gelatin hydrogels. Int J Artif Organs 2017; 40(4): 159–168.

El-Sherbiny

Yacoub

MH.

Hydrogel scaffolds for tissue engineering: progress and challenges. Glob Cardiol Sci Pract 2013; 2013(3): 316–342.

Dunn

English

Cowsar

et al . Biodegradable in-situ forming implants and methods of producing the same. Patent application 4938763A, USA, 1990.

Sartor

Eligard: leuprolide acetate in a novel sustained-release delivery system. J Urology 2003; 61(2): 25–31.

Buchter

Meyer

Kruse-Losler

et al . Sustained release of doxycycline for the treatment of peri-implantitis: randomised controlled trial. Br J Oral Maxillofac Surg 2004; 42(5): 439–444.

Patel

Carlson

Solorio

et al . Characterization of formulation parameters affecting low molecular weight drug release from in situ forming drug delivery systems. J Biomed Mater Res A 2010; 94(2): 476–484.

10.

Astaneh

Erfan

Barzin

et al . Effects of ethyl benzoate on performance, morphology, and erosion of PLGA implants formed in situ. Adv Polym Tech 2008; 27(1): 17–26.

11.

Astaneh

Erfan

Moghim

et al . Changes in morphology of in situ forming PLGA implant prepared by different polymer molecular weight and its effect on release behavior. J Pharm Sci 2009; 98(1): 135–145.

12.

Bakhshi

Vasheghani-Farahani

Mobedi

et al . The effect of additives on naltrexone hydrochloride release and solvent removal rate from an injectable in situ forming PLGA implant. Polym Advan Technol 2006; 17(5): 354–359.

13.

Zare

Mobedi

Barzin

et al . Effect of additives on release profile of leuprolide acetate in an in situ forming controlled-release system: in vitro study. J Appl Polym Sci 2008; 107(6): 3781–3787.

14.

Istvan

Deisenhofer

Structural mechanism for statin inhibition of HMG-CoA reductase. Science 2001; 292(5519): 1160–1164.

15.

Brittain

Gohil

Nair

LS.

Statins as bioactive molecules to support bone regeneration. Curr Med Chem 2014; 21(25): 2980–2988.

16.

Mundy

Garrett

Harris

et al . Stimulation of bone formation in vitro and in rodents by statins. Science 1999; 286(5446): 1946–1949.

17.

Tai

Wang

Chen

et al . Simvastatin enhances Rho/actin/cell rigidity pathway contributing to mesenchymal stem cells’ osteogenic differentiation. Int J Nanomedicine 2015; 10: 5881–5894.

18.

Whang

McDonald

Khan

et al . A novel osteotropic biomaterial OG-PLG: synthesis and in vitro release. J Biomed Mater Res 2005; 74(2): 237–246.

19.

Khayet

Feng

Khulbe

et al . Study on the effect of a non-solvent additive on the morphology and performance of ultrafiltration hollow-fiber membranes. Desalination 2002; 148(1): 321–327.

20.

Lee

Schmid

Marx

et al . The effect of local simvastatin delivery strategies on mandibular bone formation in vivo. Biomaterials 2008; 29(12): 1940–1949.

21.

Bae

Yang

Lee

et al . Photo-cured hyaluronic acid-based hydrogels containing simvastatin as a bone tissue regeneration scaffold. Biomaterials 2011; 32(32): 8161–8171.

22.

Walter

Frank

Rubert

et al . Simvastatin-activated implant surface promotes osteoblast differentiation in vitro. J Biomater Appl 2014; 28(6): 897–908.

23.

Yan

Xiao

Tan

et al . Controlled release of simvastatin-loaded thermo-sensitive PLGA-PEG-PLGA hydrogel for bone tissue regeneration: in vitro and in vivo characteristics. J Biomed Mater Res A 2015; 103(11): 3580–3589.

24.

Gentile

Nandagiri

Daly

et al . Localised controlled release of simvastatin from porous chitosan-gelatin scaffolds engrafted with simvastatin loaded PLGA-microparticles for bone tissue engineering application. Mater Sci Eng C Mater Biol Appl 2016; 59: 249–257.

25.

Nandagiri

Muttu

Daly

et al . Preparation and characterization of simvastatin loaded PLGA microparticles for tissue engineering applications. Curr Res Pharm Sci 2012; 2: 81–90.